CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 90 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | -37.5% | 2,000 | 0.0% | 0.00% | – |
| Q4 2017 | $8,000 | +60.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2017 | $5,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | +50.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2017 | $4,000 | +100.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -60.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2015 | $5,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
| Q3 2015 | $6,000 | -25.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2015 | $8,000 | -38.5% | 2,000 | -33.3% | 0.00% | – |
| Q1 2015 | $13,000 | -7.1% | 3,000 | -45.5% | 0.00% | – |
| Q2 2014 | $14,000 | +16.7% | 5,500 | 0.0% | 0.00% | – |
| Q1 2014 | $12,000 | -29.4% | 5,500 | 0.0% | 0.00% | -100.0% |
| Q3 2013 | $17,000 | – | 5,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 159,791 | $1,868 | 5.34% |
| Opaleye Management Inc. | 1,205,000 | $14,086,450 | 4.58% |
| GABLES CAPITAL MANAGEMENT INC. | 431,955 | $5,049,554 | 3.51% |
| JW Asset Management, LLC | 563,392 | $6,586,052 | 2.85% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,192,000 | $95,764,480 | 2.11% |
| Seaport Global Advisors, LLC | 45,941 | $537,050 | 1.61% |
| Capital Impact Advisors, LLC | 67,067 | $784,013 | 1.31% |
| Ikarian Capital, LLC | 505,862 | $5,913,527 | 0.71% |
| MOODY ALDRICH PARTNERS LLC | 273,512 | $3,197,355 | 0.61% |
| Paradiem, LLC | 166,905 | $1,951,119 | 0.59% |